找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Erythropoietin; Wolfgang Jelkmann,Andreas J. Gross Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 anemia.blood.cells.c

[復(fù)制鏈接]
樓主: 調(diào)停
41#
發(fā)表于 2025-3-28 14:41:37 | 只看該作者
terleukin-3 (IL-3), the colony-stimulating factors (CSF) and erythropoietin (Epo) [8, 13, 62]. While the CSF induce the proliferation and differentiation of the pluripotent and committed progenitor cells [8], maturation of the late erythroid progenitors and erythroid precursors is mainly controlled by Epo [25].
42#
發(fā)表于 2025-3-28 21:48:36 | 只看該作者
Chemistry and Assays of Erythropoietin. Epo is the principal regulatory hormone of the circulating red cell mass [1,2] and is normally present in minute concentrations in serum at 15–30 milliunits/ml, or approximately 10. . [3–5]. The study of Epo has been hampered for many years by its extreme scarcity and the lack of a convenient assay.
43#
發(fā)表于 2025-3-28 23:15:16 | 只看該作者
44#
發(fā)表于 2025-3-29 06:10:51 | 只看該作者
45#
發(fā)表于 2025-3-29 07:17:57 | 只看該作者
46#
發(fā)表于 2025-3-29 14:54:15 | 只看該作者
Recombinant Human Erythropoietinttention must be paid to its quality in the sense of a functional replacement of the natural hormone. Accordingly, a detailed comparison of the human urinary extracted form with the recombinant product is given. For better understanding, the efforts at cloning and expression of the hormone in various cellular systems are discussed.
47#
發(fā)表于 2025-3-29 17:50:07 | 只看該作者
Recombinant Human Erythropoietin and ,-Retinoic Acid Therapy of Anemia in Hemodialysis and Peritonea the deficient production of erythropoietin (EPO) by the kidney [1–3]. This is confirmed by the very recent results concerning recombinant human erythropoietin (rHuEPO) use in uremic dialysis patients, which showed that intravenous administration of this hormone leads to a significant improvement in erythropoiesis [4–6].
48#
發(fā)表于 2025-3-29 20:51:12 | 只看該作者
49#
發(fā)表于 2025-3-30 02:50:41 | 只看該作者
50#
發(fā)表于 2025-3-30 07:07:47 | 只看該作者
Overview: 978-3-642-83747-0978-3-642-83745-6
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-22 07:32
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
长岭县| 和政县| 洱源县| 双柏县| 郯城县| 长春市| 凭祥市| 宁都县| 视频| 西藏| 大兴区| 溧阳市| 宜章县| 汕头市| 奉新县| 沈丘县| 巴楚县| 邵武市| 陕西省| 江孜县| 莲花县| 遂昌县| 扎兰屯市| 富民县| 固原市| 沈丘县| 泊头市| 瑞丽市| 金门县| 高雄市| 祁连县| 孝昌县| 交城县| 平武县| 鄂托克前旗| 靖宇县| 西和县| 莆田市| 夏津县| 祁东县| 文登市|